Maine Beacon – 4/30/2020
Barbara Lawson joined a national, virtual press conference with health care advocates and federal lawmakers from her home in Hollis on Wednesday, to demand any potential drugs to treat COVID-19 are affordably priced. She asked Congress to crack down on attempts from big pharmaceutical companies to profiteer off of these drugs.
The Progressive Pulse – 4/29/20
OPED by Margarida Jorge & Pat McCoy
Daily Iowan – 4/29/2020
“A petition on the Lower Drug Prices Now website calls for Congress to require fair and reasonable prices for drugs developed using taxpayer-funded research, prevent drug companies from gaining exclusive patent rights to coronavirus drugs, and disclose details of contracts between the government and drug corporations.”
Maine Beacon – 4/29/2020
Democratic Reps. Jared Golden and Chellie Pingree say they support including safeguards against vaccine and treatment profiteering in future COVID-19 relief legislation.
There is a currently a proposal for legislation to require fair prices for all COVID-19 drugs or vaccines developed with taxpayer funds, require that no drug company be granted exclusivity for any COVID-19 vaccine or drug that may or may not be developed with taxpayer funds, and mandate that pharmaceutical manufacturers disclose how much public money they are using to create treatments and vaccines.
Des Moines Register – 3/7/20
OPED by Patrick Morissey
Maine Beacon – 3/16/20
As the Center for Disease Control (CDC) is inundated with criticism for its failure to adequately respond to the spread of COVID-19, Senator Susan Collins is now under fire for her 2018 vote to appoint Alex Azar — former president of pharmaceutical company Eli Lilly — to head the Department of Health and Human Services, which directly oversees the CDC.
